Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ: PSNL )

3.630 +0.060 (+1.68%)
Streaming Delayed Price Updated: 12:31 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
From Personalis, Inc.
Via Business Wire
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
From Personalis, Inc.
Via Business Wire
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
Personalis Named to Inc.'s 2021 Best-Led Companies List
From Personalis, Inc.
Via Business Wire
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
From Personalis, Inc.
Via Business Wire
Personalis's Return On Capital Employed Insights
Benzinga Pro data, Personalis (NASDAQ:PSNL) reported Q3 sales of $22.26 million. Earnings fell to a loss of $17.69 million, resulting in a 18.36% decrease from last quarter.... 
Via Benzinga
Personalis Reports Third Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE: 
Via Benzinga
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
From Personalis, Inc.
Via Business Wire
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
From Personalis, Inc.
Via Business Wire
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
From Personalis, Inc.
Via Business Wire
Personalis to Announce Third Quarter Financial Results on November 4, 2021
From Personalis, Inc.
Via Business Wire
Notable Personalis Insider Makes $1.9M Sale
Stephen John West, President And CEO at Personalis (NASDAQ:PSNL), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4 filing from the... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
From Personalis, Inc.
Via Business Wire
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing
From Personalis Inc.
Via Business Wire
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying
The CEO of ARK Invest is averaging down on these compelling life-science stocks. 
Via The Motley Fool
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
From Personalis, Inc.
Via Business Wire
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover. 
Via The Motley Fool
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
From Personalis, Inc.
Via Business Wire
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development
From Personalis
Via Business Wire
Return on Capital Employed Insights for Personalis
Pulled from Benzinga Pro data Personalis (NASDAQ:PSNL) reported Q2 sales of $21.67 million. Earnings fell to a loss of $14.95 million, resulting in a 19.67% decrease from last... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
Recap: Personalis Q2 Earnings
Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.24% year over year to... 
Via Benzinga
Personalis Reports Second Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
From Personalis, Inc.
Via Business Wire
Personalis to Announce Second Quarter Financial Results on August 4, 2021
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.